Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.32 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.32 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.32 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11038315 | 0.87 | HCAR2 (0.37) | LPAR2LPAR3ALDH1A1NAAADGKA | |
| SCHEMBL11039820 | 0.77 | NAAA (0.35) | LPAR2LPAR3ALDH1A1NAAADGKA | |
| SCHEMBL483170 | 0.75 | — | — | |
| SCHEMBL11038818 | 0.75 | GAA (0.44) | ALDH1A1 | |
| SCHEMBL1873270 | 0.72 | MGAM (0.46) | LPAR2LPAR3ALDH1A1ENPP2LPAR6 | |
| SCHEMBL445302 | 0.71 | ALDH1A1 (0.43) | ALDH1A1NAAADGKAHCAR2 | |
| SCHEMBL11039817 | 0.71 | NAAA (0.36) | LPAR2LPAR3ALDH1A1NAAADGKA | |
| SCHEMBL14199950 | 0.71 | NAAA (0.43) | ALDH1A1NAAADGKAHCAR2 | |
| SCHEMBL3817926 | 0.70 | — | — | |
| SCHEMBL1058897 | 0.69 | NAAA (0.41) | ALDH1A1NAAADGKAHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4436640-A | OIL ADDITIVES; EXTREME PRESSURE LUBRICANTS | CHEVRON RESEARCH COMPANY (US) | 1984-03-13 | — | — | US | disclosed |